Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: A superiority and therapeutic equivalence study

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 1, 2008, Pages 152-159

  Morice, Alyn H ^a   Peterson, Stefan ^b   Beckman, Ola ^b   Kukova, Zuzana ^c  

^a UNIVERSITY OF HULL   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

^c University Children's Hospital Bratislava   (Slovakia)

Author keywords

Asthma; Budesonide formoterol; Dry powder inhaler; Equivalence; Pressurised metered dose inhaler

Indexed keywords

BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID;

ARTICLE; ASTHMA; BRONCHITIS; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRY POWDER; EXERCISE INDUCED ASTHMA; FEMALE; FEVER; HUMAN; INFLUENZA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; PHARYNGITIS; PHASE 3 CLINICAL TRIAL; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOPHARYNGITIS; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BUDESONIDE; CHILD; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; HUMANS; HYDROCORTISONE; MALE; NEBULIZERS AND VAPORIZERS; RESPIRATORY FUNCTION TESTS; THERAPEUTIC EQUIVALENCY;

EID: 38049048580     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.01.006     Document Type: Article

References (25)

1. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. A national clinical guideline. Revised April 2004. Available at 〈www.brit-thoracic.org.uk/c2/uploads/asthmafull.pdf〉 [accessed on 12 July 2006].
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. GINA Workshop Report. NIH Publication No. 02-3659. National Institutes for Health, Bethesda, MD; 1995 [updated 2004].
3. Warner J.O., Naspitz C.K., and Cropp G.J.A. for the International Pediatric Asthma Consensus Group. Third International Pediatric Consensus statement on the management of childhood asthma. Pediatr Pulmonol 25 (1998) 1-17
4. O'Byrne P.M., Bisgaard H., Godard P.P., Pistolesi M., Palmqvist M., Zhu Y., et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 171 (2005) 129-136
5. Rabe K.F., Pizzichini E., Ställberg B., Romero S., Balanzat A.M., Atienza T., et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 129 (2006) 246-256
6. Tal A., Simon G., Vermeulen J.H., Petru V., Cobos N., Everard M.L., et al. Budesonide/formoterol in a single inhaler vs. inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol 34 (2002) 342-350
7. Dolovich M.B., Ahrens R.C., Hess D.R., Anderson P., Dhand R., Rau J.L., et al. for the American College of Chest Physicians and American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: evidence-based guidelines. Chest 127 (2005) 335-371
8. Agertoft L., and Pedersen S. Importance of training for correct Turbuhaler use in preschool children. Acta Paediatr 87 (1998) 842-847
9. StÅhl E., Ribeiro L.B., and Sandahl G. Dose response to inhaled terbutaline powder and peak inspiratory flow through Turbuhaler in children with mild to moderate asthma. Pediatr Pulmonol 22 (1996) 106-110
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225-44.
11. Juniper E.F., Guyatt G.H., Feeny D.H., Ferrie P.J., Griffith L.E., and Townsend M. Measuring quality of life in children with asthma. Qual Life Res 5 (1996) 35-46
12. Polgar G, Promadhat V. Maximal air flow rates. In: Pulmonary function testing in children: techniques and standards. Philadelphia: WB Saunders; 1971.
13. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.-C. Lung volumes and forced ventilatory flows. Report working party: standardization of lung function tests. European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J 6 Suppl. 16 (1993) 5-40
14. Juniper E.F., Guyatt G.H., Willan A., and Griffith L.E. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 47 (1994) 81-87
15. Hsu F.-F., Wang L., and Bier D.M. Determination of cortisol in human plasma by gas chromatography/negative ion chemical ionization/mass spectrometry. Ann Biochem 216 (1994) 401-405
16. Bateman E.D., Silins V., and Bogolubov M. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma. Respir Med 95 (2001) 136-146
17. TM) is effective and safe in children with asthma. Pediatr Pulmonol 30 (2000) 97-105
18. TM or pressurised metered-dose inhaler in children with asthma. Clin Drug Invest 25 (2005) 1-11
19. Bheekie A., Syce J.A., and Weinberg E.G. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies. J Clin Pharm Ther 26 (2001) 287-296
20. Fritz G.K., McQuaid E.L., Spirito A., and Klein R.B. Symptom perception in pediatric asthma: relationship to functional morbidity and psychological factors. J Am Acad Child Adolesc Psychiatry 35 (1996) 1033-1041
21. 2-agonists in management of childhood asthma: a critical review of the literature. Pediatr Pulmonol 29 (2000) 221-234
22. 2-agonists on exacerbation rates of asthma in children. Pediatr Pulmonol 36 (2003) 391-398
23. Goldsmith D.R., and Keating G.M. Budesonide/formoterol: a review of its use in asthma. Drugs 64 (2004) 1597-1618
24. McIntyre H.D., Mitchell C.A., Bowler S.D., Armstrong J.G., Wooler J.A., and Cowley D.M. Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens. Thorax 50 (1995) 1280-1284
25. ® in adolescents and adults with asthma. J Allergy Clin Immunol 115 Suppl. (2005) S3